Drug intelligence / Profile preview

xinjikang no. 1

Development stage
Unknown
Administration
Oral
01

Overview

Xinjikang No. 1 (心肌康1号) is a traditional Chinese medicine formulation primarily used for cardiovascular indications, especially for viral myocarditis and related symptoms such as palpitations, shortness of breath, chest tightness or pain, fatigue, insomnia, and other manifestations associated with qi-yin deficiency and blood stasis-heat syndrome. The product is described as having functions to tonify qi and nourish yin while promoting blood circulation and detoxification. It is typically administered in the form of granules[3]. The mechanism of action involves improving myocardial nutrition blood flow, reducing myocardial oxygen consumption, enhancing anti-hypoxia capacity, protecting against myocardial ischemia injury, expanding coronary vessels to increase coronary blood flow volume[3]. This drug is developed based on principles of traditional Chinese medicine rather than a single molecular target; its active ingredients are derived from herbal sources (specific composition may vary by manufacturer).

Brand names
心肌康1号
Other names
心肌康颗粒xinjikang granules

Beyond the preview

Go deeper on xinjikang no. 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xinjikang no. 1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call